Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.
2.

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ; EORTC Breast Cancer and Early Clinical Studies Groups..

Eur J Cancer. 2003 Nov;39(17):2439-49. Review.

PMID:
14602130
3.

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.

Seidman AD, Hudis CA, Fennelly D, Raptis G, Baselga J, Norton L.

Semin Oncol. 1995 Oct;22(5 Suppl 12):108-16. Review.

PMID:
7481852
4.
5.

Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.

Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA.

J Natl Cancer Inst. 2003 Feb 19;95(4):263-81. Review.

PMID:
12591983
6.

Quality of life analyses from vinorelbine (Navelbine) clinical trials of women with metastatic breast cancer.

Bertsch LA, Donaldson G.

Semin Oncol. 1995 Apr;22(2 Suppl 5):45-53; discussion 53-4. Review.

PMID:
7740333
7.

Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer.

Al-Batran SE, Ajani JA.

Cancer. 2010 Jun 1;116(11):2511-8. doi: 10.1002/cncr.25064. Review.

8.

Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials.

Efficace F, Bottomley A, Vanvoorden V, Blazeby JM.

Eur J Cancer. 2004 Jan;40(2):187-97. Review.

PMID:
14728932
9.

Quality of life in patients with advanced colorectal cancer: what has been learnt?

Conroy T, Bleiberg H, Glimelius B.

Eur J Cancer. 2003 Feb;39(3):287-94. Review.

PMID:
12565979
10.

Chemotherapy of advanced breast cancer.

Szántó J.

Acta Med Hung. 1994;50(3-4):185-93. Review.

PMID:
8587832
11.

Progress in understanding fatigue associated with breast cancer treatment.

Sadler IJ, Jacobsen PB.

Cancer Invest. 2001;19(7):723-31. Review.

PMID:
11577813
12.

Liposomal anthracyclines for breast cancer: overview.

O'Shaughnessy J.

Oncologist. 2003;8 Suppl 2:1-2. Review. No abstract available.

13.

[Medroxyprogesterone acetate for treatment of advanced breast cancers].

Mitsuyama S, Anan K.

Nihon Rinsho. 2000 Apr;58 Suppl:317-21. Review. Japanese. No abstract available.

PMID:
11026012
14.

Chemotherapeutic palliative approaches in the treatment of breast cancer.

Overmoyer BA.

Semin Oncol. 1995 Apr;22(2 Suppl 3):2-9. Review.

PMID:
7537899
15.

The treatment of metastatic breast cancer.

Greenberg EJ.

CA Cancer J Clin. 1991 Jul-Aug;41(4):242-56. Review.

16.

Quality of life issues in the treatment of metastatic breast cancer.

Carlson RW.

Oncology (Williston Park). 1998 Mar;12(3 Suppl 4):27-31. Review.

17.

Current status of high dose chemotherapy in breast cancer.

Glück S, Stewart D.

Przegl Lek. 2000;57 Suppl 1:30-2. Review.

PMID:
10822993
18.

Quality-of-life research in patients with breast cancer.

Winer EP.

Cancer. 1994 Jul 1;74(1 Suppl):410-5. Review.

19.

Quality of life in patients undergoing systemic therapy for advanced breast cancer.

Bottomley A, Therasse P.

Lancet Oncol. 2002 Oct;3(10):620-8. Review.

PMID:
12372724
20.

The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer.

Rogers M, Kristjanson LJ.

Cancer Nurs. 2002 Feb;25(1):57-65. Review.

PMID:
11838721
Items per page

Supplemental Content

Support Center